Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Magdy Selim, MD, PhD
Beth Israel Deaconess Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Foothills Hospital - University of Calgary
Calgary, Alberta, Canada
- University of Alberta - Mackenzie Health Sciences Centre
Edmonton, Alberta, Canada
- Chu de Québec - Hôpital de L'Enfant-Jésus
Québec, Canada
- St. Joseph'S Hospital / Barrow Neurological Institute
Phoenix, Arizona, United States
- Stanford University Medical Center
Palo Alto, California, United States
- San Francisco General Hospital
San Francisco, California, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- University of Florida
Jacksonville, Florida, United States
- Loyola University Medical Center
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Iowa Medical Center
Iowa City, Iowa, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Umass Memorial Medical Center
Worcester, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Columbia University
New York, New York, United States
- Mount Sinai Hospital
New York, New York, United States
- Nyu Langone Medical Center
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- University of North Carolina Medical Center
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University Hospital Case Medical Center
Cleveland, Ohio, United States
- the Ohio State University Medical Center
Columbus, Ohio, United States
- Oregon Health & Science University Medical Center
Portland, Oregon, United States
- University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Health Sciences Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2014
- Primary completion
- 10 Feb 2018
- Completion
- 30 May 2018
- Last update posted
- 30 May 2019
- Registered enrollment
- 294
- Registry id
- NCT02175225
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.